Meeting
2012 ASCO Annual Meeting
Outcomes of second allogeneic hematopoietic stem cell transplantation (SCT) for patients with acute lymphoblastic leukemia (ALL).
Authors
LM Poon
University of Texas M. D. Anderson Cancer Center, Houston, TX
LM Poon , Roland Bassett Jr., Gabriela Rondon , Laura L Worth , Laurence Cooper , Uday R. Popat , Yago Nieto , Marcos J.G. De Lima , Richard E. Champlin , Partow Kebriaei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Allogeneic Bone Marrow
Citation
J Clin Oncol 30, 2012 (suppl; abstr 6540)
DOI
10.1200/jco.2012.30.15_suppl.6540
Abstract #
6540
Poster Bd #
14G
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT).
First Author: Marcos J.G. De Lima
Poster
2020 ASCO Virtual Scientific Program
Incidence of graft versus host disease in peri transplant hospitalization after clostridium difficile infection.
First Author: Drew Carl Drennan Murray
Poster
2011 ASCO Annual Meeting
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).
First Author: B. M. William
Poster
2022 ASCO Annual Meeting
A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
First Author: Nicholas James Short